31 results
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
and supplier upon FDA approval of our product candidate. We have not determined the amounts we plan to spend on the areas listed above or the timing
8-K
EX-1.1
89btv tn1qvajppn
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
424B5
t5f8g
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
rhqdlwvz11bwg58
10 Dec 21
Prospectus supplement for primary offering
5:25pm
424B5
dbkw cem48vra50n5lj
10 Nov 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
o3njb6
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
424B5
jckgrdd pk0ugg
9 Nov 21
Prospectus supplement for primary offering
5:14pm